Full Text View
Tabular View
No Study Results Posted
Related Studies
Testosterone and Physical Function in HIV+ Men
This study has been completed.
Study NCT00260143   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

First Received on November 29, 2005.   Last Updated on January 14, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Associate Weight Loss
Additional conditions recognized in this trial
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Signs and Symptoms
Interventions listed in this trial
testosterone enanthate
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services